FindTrial
Sign In

Study on the effects of homeopathic drug Folliculinum on E coli bacteria of urinary tract infected patients in laboratory and clinical verification of same.

In vitro study of homeopathic drug-Folliculinum in different potencies on cultured Escherichia coli and its clinical verification in patients with urinary tract infection.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031069
Enrollment
70
Registered
2021-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N300- Acute cystitis

Interventions

Intervention1: FOLLICULINUM 12C,30,200,1M 1M POTENCY: SMEDICINE GIVEN IN SINGLE DOSE POTENCY ORALLY AT AN INTERVEL OF 2 WEEK ACCORDING TO PATIENTS NEED. Control Intervention1: INDIDUALISED HOMEOPATHIC

Sponsors

AFIYA ALLOOR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: positive findings in urine microscopy and culture Children aged below 10 and Female aged between 20 - 50 years. patients willing to give written consent to participate in the trial.

Exclusion criteria

Exclusion criteria: 1. Infected material of patients suffering a sexually transmitted disease like HIV, syphilis, gonorrhea, Kaposi sarcoma etc. Cases with a severe systemic illness like meningitis and septicemia. Patients having malignancy from any origin.

Design outcomes

Primary

MeasureTime frame
Reducing the bacterial colony count in urine cultureTimepoint: 2 MONTHS INTERVEL—

Secondary

MeasureTime frame
Inhibition of bacterial growthTimepoint: 2 WEEKS—

Countries

India

Contacts

Public ContactAFIYA ALLOOR

GOVT HOMEOPATHIC MEDICAL COLLEGE KOZHIKODE

similima@yahoo.com9249337799

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026